Take action – write to Parkinson's UK
Animal Aid has discovered that Parkinson’s UK, through their drug development arm, will provide more than £780,000 for work which will include testing a drug on primates. The work will be in partnership with a drug company – Neurolixis – and with King’s College London, which has a colony of marmoset monkeys.
No details are given about what will be done to the monkeys, but the usual way to ‘model’ Parkinson’s Disease (PD) in monkeys is to inject them with a toxic chemical which results in terrible symptoms. These can include paralysis, total loss (or extreme slowness) of movement, rigidity, loss of vocalisation and uncontrollable tremors.
Please contact Steve Ford, Chief Executive of Parkinson’s UK, to object to them funding experiments on monkeys.